COMMUNIQUÉS West-GlobeNewswire

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/11/2026
BRANFORD, Conn., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein [...]
NACHC Returns to HLTH 2026 to Showcase How Community Health Centers are Scaling Innovation
13/11/2026
Bethesda, Nov. 13, 2026 (GLOBE NEWSWIRE) -- BETHESDA, Md. – November 13, 2026 – The National Association of Community Health Centers (NACHC) is returning to the 2026 HLTH USA conference . As the voice of the nation’s 1, [...]
TRexBio Reports Third Quarter 2026 Financial Results and Recent Business Highlights
13/11/2026
Positive Phase 1a results for TRB-061 support proof of mechanism, with topline Phase 1b data in atopic dermatitis expected in mid-2027 TRB-071 advancing through IND-enabling studies, with Phase 1 trial initiation [...]
Femasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Update
13/11/2026
$30 million private placement supports commercial team build-out to drive U.S. sales growth; Q3 U.S. sales increased slightly despite significant funding constraints prior to mid-August financing ATLANTA, Nov. 13, 2026 [...]
4DMT Announces New Employment Inducement Grants
13/11/2026
EMERYVILLE, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
13/11/2026
NEW YORK, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a biotechnology company dedicated to immunotherapy research, today announced financial results for [...]
Vistagen Reports Fiscal Year 2027 Second Quarter Financial Results and Provides Corporate Update
13/11/2026
Advancing potential to execute Phase 3 development plan for fasedienol in social anxiety disorder following constructive FDA feedback, with disciplined capital management and strategic flexibility SOUTH SAN FRANCISCO, [...]
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
13/11/2026
CAMBRIDGE, Mass., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a clinical-stage biopharmaceutical company leveraging a novel oligonucleotide promoted editing of RNA (OPERA ® ) platform to [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
13/11/2026
ZUG, Switzerland, Nov. 13, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company. Attachments Notification of managers' [...]
Natural Alternatives International, Inc. Announces Fiscal 2027 Q1 Results
13/11/2026
CARLSBAD, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced [...]
Cingulate Inc. Reports Third Quarter 2026 Financial Results and Provides Regulatory Update on CTx-1301 NDA Resubmission
13/11/2026
Manufacturing Work Addressing FDA CMC Information Requests Substantially Completed NDA Resubmission Expected Between December 2026 and January 2027 KANSAS CITY, Kan., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. ( [...]
Tempest Reports Third Quarter 2026 Financial Results and Provides Business Update
13/11/2026
Exclusively licensed Senlang’s CD7-Targeted lentiviral in vivo CAR-T platform following initial Phase 1 results with lead BCMA/GPRC5D candidate TPST-4903 Secured access to additional capital through an equity line of [...]
Calidi Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
13/11/2026
- Continued to advance the development of CLD-401 towards the clinic - Presented new CLD-401 data and in situ TCE platform advances at the ESMO Congress 2026 - Received $1.2 million gross proceeds from at-the-market [...]
BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update
13/11/2026
FDA Fast Track Designation for Plinabulin plus docetaxel marks key regulatory milestone in DUBLIN-4 study population of Post-ICI Non-Squamous NSCLC with no actionable genomic alteration (AGA) Strategic transaction with [...]
Cerenome Reports Third Quarter 2026 Financial Results and Business Highlights Featuring REYOBIQ ReSPECT- LM Data and CNSide Commercial and Reimbursement Progress
13/11/2026
HOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted [...]
XORTX Patent Allowed for XRx-101 Program by Japan Patent Office
13/11/2026
Japan Patent Office allows claims directed to xanthine oxidase inhibitor compositions for acute kidney injury and other health consequences of viral infection; once registered, patent expected to remain in force until [...]
Oncolytics Biotech® Announces Clinical Supply Agreement to Evaluate Pelareorep in Combination with LOQTORZI® (toripalimab-tpzi) in SCAC
13/11/2026
Pelareorep and toripalimab combine potentially complementary mechanisms designed to enhance antitumor immune responses and help overcome tumor immune resistance Study may represent a first step toward evaluating the [...]
Pennant Group to Participate in the 2026 Stephens Annual Investment Conference
13/11/2026
EAGLE, Idaho, Nov. 13, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Kura Oncology to Participate in Two Investor Conferences in November
13/11/2026
SAN DIEGO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced that management will present at [...]

Pages